Blood Test May Point to Patients at Higher Risk for COVID-19 Deterioration, Death

George Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.

Read more

ECS Community on the Frontline of COVID-19 Research

In our series, The ECS Community Adapts and Advances, Netzahualcóyotl (Netz) Arroyo-Currás talks about his lab’s challenge as part of the pandemic response of Johns Hopkins Medicine, which is at the forefront of COVID-19 research. Soon after classes went online and labs were shuttered, his team shifted gears to quickly design a COVID-19 diagnostic device to help meet the urgent need to re-open work and study environments.

Read more

Tackling COVID-19 with Optimism and Ingenuity

Joe Stetter is an optimist, inventor, entrepreneur, and owner of two small businesses that stayed open through the lockdown. KWJ Engineering and Spec Sensors manufacture essential health and safety sensors with medical and industrial applications. In our series, The ECS Community Adapts and Advances, Joe shares the challenges of doing business “not as usual”, and reports on a research collaboration he mobilized to improve PPE sterilization for COVID-19 frontline workers.

Read more

Memorial Sloan Kettering Awards and Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

Read more

Lack of lockdown increased COVID-19 deaths in Sweden

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Read more

Montefiore and Einstein Test a New Drug Combination to Conquer COVID-19

Montefiore Health System and Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection. The new iteration of the trial, known as ACTT 2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Read more

UTHealth is joining forces with the White House Office of Science and Technology Policy and NIST on COVID-19 search engine effort

The University of Texas Health Science Center at Houston (UTHealth) has teamed up with the White House Office of Science and Technology Policy and the National Institute of Standards and Technology (NIST) to develop search engines that will help streamline COVID-19 research for health care experts fighting the virus.

Read more